A
Acurion
United States · Healthtech · Biotech · AI
AI analysis of routine pathology images to identify cancer biomarkers for precision oncology.
Biomarker information from existing slides
Acurion develops OncoGaze, a platform that analyses conventional pathology images for cancer biomarker information. Its approach uses slides already prepared during clinical care, aiming to help clinicians and researchers obtain information relevant to treatment selection without a separate molecular-testing workflow. The technology is undergoing clinical validation and regulatory preparation.
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4.3M | Asian Fund for Cancer Research — Role not disclosedBootstrap Ventures — Role not disclosedMesa Verde Venture Partners — Role not disclosedThe National Foundation for Cancer Research — Role not disclosedTK & Partners — Role not disclosed |